Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

In the year 2025, Iovance Biotherapeutics had annual revenue of $263.50M with 60.60% growth. Iovance Biotherapeutics had revenue of $86.77M in the quarter ending December 31, 2025, with 17.74% growth.

• Revenue (ttm): $263.50M
• Revenue Growth: +60.60%
• P/S Ratio: 6.03
• Revenue / Employee: $270,258
• Employees: 975
• Market Cap: 1.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	263.50M	99.43M	60.60%
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-